State Health Plan spending on GLP-1 drugs such as Wegovy rose from about $3 million per month in around 2021-2022 to more than $14 million per month in 2023, making In 2023, the drugs accounted for roughly 10% of the $1 billion the plan spends on all prescription drugs
Both SLC25A12 and SLC25A13 as well as SLC25A22 make up the mitochondrial glutamine transport system with SLC25A22 showing greater specificity for transporting glutamine
Supplementation is most impactful in individuals with compromised hepatic glutathione stores NAFLD, alcohol use, chronic medication exposure, or environmental toxin burden
While there is preliminary evidence from clinical trials supporting the potential therapeutic benefits of oral ingestion of BPC-157, more research is needed to fully understand its mechanisms of action and evaluate its safety and efficacy for oral administration in different clinical conditions, including inflammatory bowel disease and and human gastric juices
Complete your health profile online
